| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.04 |